[go: up one dir, main page]

AR105922A1 - 1 - ((6-METOXINAFTALEN-2-IL) METHYL) -4- (3,3,3-TRIFLUOROPROPANOIL) OCTAHIDRO-1H-2,6-METANOPIRROLO [3,2-B] PIRIDIN-3-IL-USEFUL PIVALATE IN PAIN TREATMENT - Google Patents

1 - ((6-METOXINAFTALEN-2-IL) METHYL) -4- (3,3,3-TRIFLUOROPROPANOIL) OCTAHIDRO-1H-2,6-METANOPIRROLO [3,2-B] PIRIDIN-3-IL-USEFUL PIVALATE IN PAIN TREATMENT

Info

Publication number
AR105922A1
AR105922A1 ARP160102709A ARP160102709A AR105922A1 AR 105922 A1 AR105922 A1 AR 105922A1 AR P160102709 A ARP160102709 A AR P160102709A AR P160102709 A ARP160102709 A AR P160102709A AR 105922 A1 AR105922 A1 AR 105922A1
Authority
AR
Argentina
Prior art keywords
trifluoropropanoil
metoxinaftalen
metanopirrolo
octahidro
piridin
Prior art date
Application number
ARP160102709A
Other languages
Spanish (es)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of AR105922A1 publication Critical patent/AR105922A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

La presente solicitud proporciona el compuesto y esteroisómeros, sales farmacéuticamente aceptables, métodos para elaborar, composiciones farmacéuticas que contienen tales compuestos, y el uso de estos compuestos en métodos para tratar afecciones, enfermedades, o trastornos. Reivindicación 1: Un compuesto de fórmula (1), o un esteroisómero, sal farmacéuticamente aceptable o mezcla de este.The present application provides the compound and stereoisomers, pharmaceutically acceptable salts, methods for making, pharmaceutical compositions containing such compounds, and the use of these compounds in methods for treating conditions, diseases, or disorders. Claim 1: A compound of formula (1), or a stereoisomer, pharmaceutically acceptable salt or mixture thereof.

ARP160102709A 2015-09-04 2016-09-05 1 - ((6-METOXINAFTALEN-2-IL) METHYL) -4- (3,3,3-TRIFLUOROPROPANOIL) OCTAHIDRO-1H-2,6-METANOPIRROLO [3,2-B] PIRIDIN-3-IL-USEFUL PIVALATE IN PAIN TREATMENT AR105922A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562214727P 2015-09-04 2015-09-04

Publications (1)

Publication Number Publication Date
AR105922A1 true AR105922A1 (en) 2017-11-22

Family

ID=60452274

Family Applications (9)

Application Number Title Priority Date Filing Date
ARP160102707A AR105920A1 (en) 2015-09-04 2016-09-05 THERAPEUTIC COMPOUND FOR THE PAIN AND SYNTHESIS OF THE COMPOUND
ARP160102710A AR105923A1 (en) 2015-09-04 2016-09-05 THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS OF THESE
ARP160102708A AR105921A1 (en) 2015-09-04 2016-09-05 THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS OF THESE
ARP160102709A AR105922A1 (en) 2015-09-04 2016-09-05 1 - ((6-METOXINAFTALEN-2-IL) METHYL) -4- (3,3,3-TRIFLUOROPROPANOIL) OCTAHIDRO-1H-2,6-METANOPIRROLO [3,2-B] PIRIDIN-3-IL-USEFUL PIVALATE IN PAIN TREATMENT
ARP160102711A AR105924A1 (en) 2015-09-04 2016-09-05 THERAPEUTIC COMPOUNDS AND SYNTHESIS
ARP180101035A AR111416A2 (en) 2015-09-04 2018-04-23 THERAPEUTIC COMPOUND FOR THE PAIN AND SYNTHESIS OF THE COMPOUND
ARP180101047A AR113298A2 (en) 2015-09-04 2018-04-24 METHOD FOR PREPARING A BRIDGED DERIVATIVE OF PIVALATE FROM SPOOLAMINE
ARP180101061A AR111423A2 (en) 2015-09-04 2018-04-25 THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS OF THESE
ARP180101062A AR111424A2 (en) 2015-09-04 2018-04-25 PREPARATION METHOD OF 1 - ((6-METOXINAFTALEN-2-IL) METHYL) -4- (3,3,3-TRIFLUROPROPANOL) OCTAHIDRO-1H-2,6-METANOPIRROLO [3,2-B] PIRIDIN-3- IL PIVALATO

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ARP160102707A AR105920A1 (en) 2015-09-04 2016-09-05 THERAPEUTIC COMPOUND FOR THE PAIN AND SYNTHESIS OF THE COMPOUND
ARP160102710A AR105923A1 (en) 2015-09-04 2016-09-05 THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS OF THESE
ARP160102708A AR105921A1 (en) 2015-09-04 2016-09-05 THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS OF THESE

Family Applications After (5)

Application Number Title Priority Date Filing Date
ARP160102711A AR105924A1 (en) 2015-09-04 2016-09-05 THERAPEUTIC COMPOUNDS AND SYNTHESIS
ARP180101035A AR111416A2 (en) 2015-09-04 2018-04-23 THERAPEUTIC COMPOUND FOR THE PAIN AND SYNTHESIS OF THE COMPOUND
ARP180101047A AR113298A2 (en) 2015-09-04 2018-04-24 METHOD FOR PREPARING A BRIDGED DERIVATIVE OF PIVALATE FROM SPOOLAMINE
ARP180101061A AR111423A2 (en) 2015-09-04 2018-04-25 THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS OF THESE
ARP180101062A AR111424A2 (en) 2015-09-04 2018-04-25 PREPARATION METHOD OF 1 - ((6-METOXINAFTALEN-2-IL) METHYL) -4- (3,3,3-TRIFLUROPROPANOL) OCTAHIDRO-1H-2,6-METANOPIRROLO [3,2-B] PIRIDIN-3- IL PIVALATO

Country Status (1)

Country Link
AR (9) AR105920A1 (en)

Also Published As

Publication number Publication date
AR105920A1 (en) 2017-11-22
AR113298A2 (en) 2020-04-08
AR105921A1 (en) 2017-11-22
AR105923A1 (en) 2017-11-22
AR111423A2 (en) 2019-07-10
AR111424A2 (en) 2019-07-10
AR105924A1 (en) 2017-11-22
AR111416A2 (en) 2019-07-10

Similar Documents

Publication Publication Date Title
NZ777871A (en) Small molecule modulators of il-17
PH12019502245A1 (en) Compounds that inhibit mcl-1 protein
MX2019000451A (en) HETEROCYCLIC COMPOUND USED AS AN INHIBITOR OF FGFR.
SA518400660B1 (en) Pyrimidin-2-Ylamino-1h-Pyrazols as Lrrk2 Inhibitors for Use in The Treatment of Neurodegenerative Disorders
MX2017010477A (en) Tricyclic compounds and uses thereof in medicine.
MX2018012901A (en) DEMETILASE 1 INHIBITOR FORMULATIONS SPECIFIC FOR LYSINE (LSD1).
UA109698C2 (en) AZAINDASOL OR DIAZAINDASOL DERIVATIVES AS A MEDICINE
EA201891191A1 (en) 2-SUBSTITUTED HINAZOLIN COMPOUNDS CONTAINING A SUBSTITUTED HETEROCYCLIC GROUP AND METHODS OF THEIR APPLICATION
UY37133A (en) DERIVATIVES OF PIRAZOLO [1,5-A] PIRAZIN-4-ILO
GEP20207105B (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors
NZ708593A (en) Novel pyrazole derivative
MX2017006832A (en) Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof.
MX2016001400A (en) 1,4-disubstituted pyridazine derivatives and their use for treating smn-deficiency-related conditions.
MY188700A (en) Bicyclic ketone sulfonamide compounds
UY37837A (en) NEW HETEROCYCLIC COMPOUNDS AS INHIBITORS OF CDK8 / 19
MX2021010122A (en) IMIDAZOPYRIDINYL COMPOUNDS AND THEIR USE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS.
PH12016502353A1 (en) Pharmaceutical composition
UY36875A (en) BROMODOMINIUM INHIBITING COMPOSITIONS FOR THE TREATMENT OF VARIOUS DISEASES
MX2016011105A (en) Dihydropyridinone mgat2 inhibitors for use in the treatment of metabolic disorders.
CO2021003391A2 (en) N-substituted dioxocyclobutenylamino-3-hydroxy-picolinamides useful as ccr6 inhibitors
EA201692481A1 (en) COMBINATION CONTAINING GLUCOCORTICOID AND EDO-S101
MX2020013694A (en) Heterocyclic compound as trk inhibitor.
SA519402103B1 (en) 1, 6- Naphthyridine as CDK4/6 Inhibitor
MX2020008498A (en) Derivatives of sobetirome.
EA201991355A1 (en) IMIDAZO [1,5-A] PYRASINE DERIVATIVES AS PI3K DELTA INHIBITORS

Legal Events

Date Code Title Description
FB Suspension of granting procedure